Follow the HLB stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, HLB has logged 28 public disclosures. Market capitalisation: €543.1bn. The latest transaction was filed on 1 September 2022 (Other). Among the most active insiders: 진양곤. The full history is openly available.
28
Insider Decl.
0
Thresholds
·
4 ops.
Buy Volume
·
0 ops.
Sell Volume
11Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 23,869 of 25,484 companies
17.7
score / 100
Value
20
Quality
15
FCF yld-5.7%
Earn yld-6.1%
EV/EBITDA·
ROE-14%
Gross mgn13%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.